www.cytivalifesciences.com
Open in
urlscan Pro
172.64.152.91
Public Scan
Submitted URL: https://informmeddireng.com/c/1855393/8d5802a80f679d0a/1
Effective URL: https://www.cytivalifesciences.com/en/gb
Submission: On July 02 via manual from GB — Scanned from GB
Effective URL: https://www.cytivalifesciences.com/en/gb
Submission: On July 02 via manual from GB — Scanned from GB
Form analysis
1 forms found in the DOMPOST /gb
<form action="/gb" id="__AjaxAntiForgeryForm" method="post"><input name="__RequestVerificationToken" type="hidden" value="lWIZDu0C3kNzJMvc8SezbpKznrxoh8LRAcUUrXIoKqv8HeXf4VOWRpriE0q-D7cWqa3bICzl4ulYs9raE-gO-rgtXdk1"></form>
Text Content
Clear SearchLoading Quotes 0 0 Cart 0 0 * Products * Applications * Service & Support * Resources * Our Company * Quick Order Track Order Register/Log in SCALE RIGHT THE FIRST TIME HARNESS THE POWER OF DIGITAL SOLUTIONS TO MINIMIZE RISK Explore Bioreactor Scaler Which type of workflow are you interested in? mAbs mRNA Cell therapy manufacturing Viral vectors KNOWLEDGE AT YOUR FINGERTIPS Visit our knowledge center for insights that will help you advance your work Discover now RESEARCH AND INDUSTRY JOIN FORCES AS MODALITIES MERGE How will the era of creativity play out for advanced therapies? Read more TRENDS IN IMMUNODIAGNOSTICS From nanoparticles to AI, novel technologies are shaping the future Learn how RECENT NEWS PIERRE-ALAIN RUFFIEUX JOINS CYTIVA AS CHIEF OPERATING OFFICER CYTIVA’S LATEST INNOVATION SIGNIFICANTLY IMPROVES FILTRATION OF HIGH CONCENTRATION BIOLOGICS INNOVATION AND AUTOMATION ARE DRIVING FORCES BEHIND NEXT GENERATION CELL THERAPY MANUFACTURING PLATFORM FROM CYTIVA CYTIVA CONTINUES ITS SUPPORT FOR N-LOREM FOUNDATION RIBOBAY PHARMA BOOSTS CRDMO OFFERINGS WITH CYTIVA’S FIRST FLEXFACTORY PLATFORM FOR OLIGONUCLEOTIDES CYTIVA INTRODUCES NEW CELL LINES TO MEET THE CHALLENGES AND INCREASING DEMAND OF VIRAL VECTOR MANUFACTURING 加速本土化,CYTIVA重磅发布国产标准化ÄKTA READY EXTENDED一次性层析系统 AGC BIOLOGICS SELECTS CYTIVA TO PROVIDE FLEXFACTORY PLATFORMS IN NEW BIOMANUFACTURING FACILITY IN JAPAN CYTIVA UNVEILS LATEST INNOVATION FOR LARGE SCALE MAB, VACCINE, AND ADVANCED THERAPY MANUFACTURING PROCESSES - THE XCELLEREX COMPACT SINGLE-USE MAGNETIC MIXING SYSTEM * * * Read more CAREERS Explore opportunities to work with our extraordinary team SERVICE & SUPPORT Find online tools, product documentation and service support E-LEARNING Build your skills and continue your education with our eLearning courses CONTACT US Customer service, orders, scientific and technical questions Shop our products * How to shop with us * Find products * Redeem your quote * Special offers * Track order * Shipping information * Returns * Remanufactured products * Find a distributor Applications * Bioprocessing * Cell and gene therapy * Diagnostics * Emerging biotech * Enterprise solutions * Genomics * Lab filtration * Medical * Protein research Support * LifeCycle support solutions * Regulatory support * Change Control Notifications * Scientific support * Certificate search * Handbooks * Instructions for use * Safety data sheets/SDS * Tools and calculators * Training Our company * About us * News center * Careers * Behind Biopharma * Sustainability * Contact us United Kingdom -------------------------------------------------------------------------------- * © 2024 Cytiva * Terms· * Privacy· * Cookies· * Trademarks· * Preferences· * * * * WHY AM I ON CYTIVA.COM? On May 1 the biotechnology, laboratory and medical businesses of Pall Corporation became part of Cytiva. You'll now find the same great Pall products and content hosted here. Continue Learn more YOUR PRIVACY We use cookies to improve your experience on our website and to show you personalized content. You can allow all, or control these by clicking 'Manage cookies'. Reject all Allow cookies Manage cookies x